We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
301
Goldman Sachs
GS
$303B
$6.73M 0.04%
32,873
+20,383
+163% +$4.03M
ORLY icon
302
O'Reilly Automotive
ORLY
$76.3B
$6.63M 0.04%
269,160
+221,055
+460% +$5.6M
NTRS icon
303
Northern Trust
NTRS
$33.9B
$6.58M 0.04%
73,116
-64,121
-47% -$5.91M
PEG icon
304
Public Service Enterprise Group
PEG
$37.7B
$6.55M 0.04%
+111,433
New +$6.64M
BWA icon
305
BorgWarner
BWA
$13.9B
$6.52M 0.04%
176,327
+174,055
+7,661% +$6.17M
CL icon
306
Colgate-Palmolive
CL
$74.4B
$6.51M 0.04%
90,860
+43,458
+92% +$3.09M
KT icon
307
KT
KT
$8.81B
$6.46M 0.04%
522,187
+391,803
+300% +$4.77M
CVS icon
308
CVS Health
CVS
$122B
$6.4M 0.04%
+117,503
New +$6.33M
TSN icon
309
Tyson Foods
TSN
$20.4B
$6.39M 0.04%
79,139
+74,539
+1,620% +$5.74M
XNCR icon
310
Xencor
XNCR
$1.55B
$6.38M 0.04%
155,743
+155,304
+35,377% +$5.1M
P
311
Everpure Inc
P
$29.9B
$6.31M 0.04%
+413,432
New +$8.08M
ARW icon
312
Arrow Electronics
ARW
$10.4B
$6.29M 0.04%
+88,215
New +$6.5M
QCOM icon
313
Qualcomm
QCOM
$176B
$6.28M 0.04%
82,501
-21,109
-20% -$1.55M
FMS icon
314
Fresenius Medical Care
FMS
$12.9B
$6.27M 0.04%
159,652
+32,016
+25% +$1.27M
BMY icon
315
Bristol-Myers Squibb
BMY
$132B
$6.27M 0.04%
138,230
-423,615
-75% -$19.7M
VALE icon
316
Vale
VALE
$62.6B
$6.23M 0.04%
463,325
+242,304
+110% +$3.11M
AGNC icon
317
AGNC Investment
AGNC
$12.9B
$6.18M 0.04%
+367,250
New +$6.38M
BLMN icon
318
Bloomin' Brands
BLMN
$937M
$6.17M 0.04%
326,101
+238,555
+272% +$4.66M
WING icon
319
Wingstop
WING
$3.18B
$6.14M 0.04%
+64,805
New +$5.28M
SWI
320
DELISTED
SolarWinds Corporation Common Stock
SWI
$6.09M 0.04%
314,849
+198,032
+170% +$3.89M
HST icon
321
Host Hotels & Resorts
HST
$16B
$6.09M 0.04%
334,236
+125,384
+60% +$2.36M
NGVT icon
322
Ingevity
NGVT
$2.68B
$6.04M 0.04%
57,382
+56,971
+13,862% +$5.72M
SHOP icon
323
Shopify
SHOP
$195B
$6M 0.04%
199,480
+119,420
+149% +$3.11M
FRT icon
324
Federal Realty Investment Trust
FRT
$10.3B
$5.92M 0.04%
45,931
+45,801
+35,232% +$6.08M
TD icon
325
Toronto Dominion Bank
TD
$200B
$5.92M 0.04%
101,000
+26,000
+35% +$1.46M
11 12
13
14 15

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.